Total Hip Arthroplasty Outcomes in Patients Who Have a History of Prior Radiation

• Published in: The Journal of arthroplasty Vol. 38; no. 12; pp. 2644 - 2649
• Main Authors: Lavu, Monish S, Hecht, 2nd, Christian J, Rizk, Adam A, Acuña, Alexander J, Kaelber, David C, Kamath, Atul F
• Format: Journal Article
• Language: English
• Published: United States 01-12-2023
• Subjects: Antineoplastic Agents; Arthroplasty, Replacement, Hip - adverse effects; Humans; Neoplasms - complications; Postoperative Complications - epidemiology; Postoperative Complications - etiology; Pulmonary Embolism - etiology; Reoperation - adverse effects; Retrospective Studies; Risk Factors; radiotherapy; total hip arthroplasty; adverse events; complications; radiation therapy
• ISSN: 0883-5403; 1532-8406
• DOI: 10.1016/j.arth.2023.05.066

The purpose of this study was to assess the odds of developing medical and surgical adverse events following total hip arthroplasty (THA) in patients who have a history of radiation therapy (RT) for cancer.
A retrospective cohort study was conducted using a national database to identify patients who underwent primary THA (Current Procedural Terminology code 27130) from 2002 to 2022. Patients who had a prior RT were identified by International Classification of Diseases, Tenth Revision, Clinical Modification codes Z51.0 (encounter for antineoplastic RT), Z92.3 (personal history of irradiation), or Current Procedural Terminology code 101843 (radiation oncology treatment). One-to-one propensity score matching was conducted to generate 3 pairs of cohorts: 1) THA with/without a history of RT; 2) THA with/without a history of cancer; and 3) THA patients who have a history of cancer treated with/without RT. Surgical and medical complications were assessed at the 30-day, 90-day, and 1-year postoperative periods.
Patients who have a history of RT had higher odds of developing anemia, deep vein thrombosis, pneumonia, pulmonary embolism, and prosthetic joint infection at all intervals. When controlling for a history of cancer, RT was associated with an increased risk of pulmonary embolism, heterotrophic ossification, prosthetic joint infection, and periprosthetic fracture at all postoperative time points. There was additionally an increased risk of aseptic loosening at 1 year (odds ratio: 2.0, 95% confidence interval: 1.2 to 3.1).
These findings suggest that patients who have a history of antineoplastic RT are at an increased risk of developing various surgical and medical complications following THA.